These findings suggest that lymph node metastasis and recurrence in OSCC are associated with increases in PD1 and glycolysis in CD4+ T cells; this response may serve as a potential regulator of OSCC progression. Here, CD4 is linked to metastatic malignant neoplasm in the lymph nodes.